Deerfield Management Company, L.P. (Series C) United Therapeutics Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.37 Billion
- Q3 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in United Therapeutics Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 425,993 shares of UTHR stock, worth $199 Million. This represents 3.32% of its overall portfolio holdings.
Number of Shares
425,993
Previous 540,626
21.2%
Holding current value
$199 Million
Previous $155 Million
14.95%
% of portfolio
3.32%
Previous 3.57%
Shares
3 transactions
Others Institutions Holding UTHR
# of Institutions
807Shares Held
41.4MCall Options Held
1.56MPut Options Held
2.87M-
Black Rock Inc. New York, NY5.47MShares$2.55 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$2.06 Billion0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.17MShares$1.01 Billion1.29% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$943 Million11.58% of portfolio
-
State Street Corp Boston, MA1.92MShares$897 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $21.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...